论文部分内容阅读
激光-血卟啉对眼部浅表肿瘤已显示出其一定的疗效,并便于观察。对占眼内肿瘤第一位的视网膜母细胞瘤,国外已在实验及临床方面获得了某些成功,我院在1983年对5例视网膜母细胞瘤进行了激光-血卟啉治疗,并详细观察了其临床反应及病理改变。现将初步结果报告如下: (一)、材料及方法采用国产血卟啉,系北京制药工业研究所产品,按每公斤体重2.5毫克计算,注射前行皮肤划痕试验阴性后,再行静脉注射,注射后
Laser-hematoporphyrin has shown a certain effect on superficial tumors of the eye and is easy to observe. For retinoblastoma, which is the first in the intraocular tumor, foreign countries have obtained some successes in experimental and clinical aspects. In our hospital in 1983, 5 cases of retinoblastoma were treated with laser-hematoporphyrin and detailed Observed its clinical response and pathological changes. The preliminary results are now reported as follows: (1) Materials and methods Domestic hematoporphyrins are used, which is a product of the Beijing Institute of Pharmaceutical Industry. Calculated at 2.5 mg per kilogram of body weight. Before the injection, the skin scratch test is negative and then the intravenous injection is performed. After injection